Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 184

1.

First Hospitalization for Heart Failure in Outpatients With Stable Coronary Artery Disease: Determinants, Role of Incident Myocardial Infarction, and Prognosis.

Lamblin N, Meurice T, Tricot O, de Groote P, Lemesle G, Bauters C.

J Card Fail. 2018 Dec;24(12):815-822. doi: 10.1016/j.cardfail.2018.09.013. Epub 2018 Oct 5.

PMID:
30296582
2.

Haemodynamics and serial risk assessment in systemic sclerosis associated pulmonary arterial hypertension.

Weatherald J, Boucly A, Launay D, Cottin V, Prévot G, Bourlier D, Dauphin C, Chaouat A, Savale L, Jaïs X, Jevnikar M, Traclet J, De Groote P, Simonneau G, Hachulla E, Mouthon L, Montani D, Humbert M, Sitbon O.

Eur Respir J. 2018 Oct 18;52(4). pii: 1800678. doi: 10.1183/13993003.00678-2018. Print 2018 Oct.

PMID:
30209196
3.

Pulmonary hypertension in chronic heart failure: definitions, advances, and unanswered issues.

Berthelot E, Bauer F, Eicher JC, Flécher E, Gellen B, Guihaire J, Guijarro D, Roul G, Salvat M, Tribouilloy C, Zores F, Lamblin N, de Groote P, Damy T.

ESC Heart Fail. 2018 Oct;5(5):755-763. doi: 10.1002/ehf2.12316. Epub 2018 Jul 20. Review.

4.

Expression and Implication of Clusterin in Left Ventricular Remodeling After Myocardial Infarction.

Turkieh A, Fertin M, Bouvet M, Mulder P, Drobecq H, Lemesle G, Lamblin N, de Groote P, Porouchani S, Chwastyniak M, Beseme O, Amouyel P, Mouquet F, Balligand JL, Richard V, Bauters C, Pinet F.

Circ Heart Fail. 2018 Jun;11(6):e004838. doi: 10.1161/CIRCHEARTFAILURE.117.004838.

PMID:
29891738
5.

Accuracy of cardiac magnetic resonance imaging to rule out significant coronary artery disease in patients with systolic heart failure of unknown aetiology: Single-centre experience and comprehensive meta-analysis.

Manchuelle A, Pontana F, De Groote P, Lebert P, Fertin M, Baijot M, Hurt C, Lamblin N, Debry N, Schurtz G, Pentiah AD, Sudre A, Remy-Jardin M, Lancellotti P, Van Belle E, Bauters C, Lemesle G, Delhaye C.

Arch Cardiovasc Dis. 2018 Nov;111(11):686-701. doi: 10.1016/j.acvd.2018.04.004. Epub 2018 Jun 1.

PMID:
29861294
6.

Dual-energy CT (DECT) lung perfusion in pulmonary hypertension: concordance rate with V/Q scintigraphy in diagnosing chronic thromboembolic pulmonary hypertension (CTEPH).

Masy M, Giordano J, Petyt G, Hossein-Foucher C, Duhamel A, Kyheng M, De Groote P, Fertin M, Lamblin N, Bervar JF, Remy J, Remy-Jardin M.

Eur Radiol. 2018 Dec;28(12):5100-5110. doi: 10.1007/s00330-018-5467-2. Epub 2018 May 30.

PMID:
29846802
7.

RIPK4 activity in keratinocytes is controlled by the SCFβ-TrCP ubiquitin ligase to maintain cortical actin organization.

Tanghe G, Urwyler-Rösselet C, De Groote P, Dejardin E, De Bock PJ, Gevaert K, Vandenabeele P, Declercq W.

Cell Mol Life Sci. 2018 Aug;75(15):2827-2841. doi: 10.1007/s00018-018-2763-6. Epub 2018 Feb 12.

PMID:
29435596
8.

Keratinocyte-Specific Ablation of RIPK4 Allows Epidermal Cornification but Impairs Skin Barrier Formation.

Urwyler-Rösselet C, Tanghe G, Leurs K, Gilbert B, De Rycke R, De Bruyne M, Lippens S, Bartunkova S, De Groote P, Niessen C, Haftek M, Vandenabeele P, Declercq W.

J Invest Dermatol. 2018 Jun;138(6):1268-1278. doi: 10.1016/j.jid.2017.12.031. Epub 2018 Jan 6.

PMID:
29317263
9.

Assessment of potential heart donors: A statement from the French heart transplant community.

Dorent R, Gandjbakhch E, Goéminne C, Ivanes F, Sebbag L, Bauer F, Epailly E, Boissonnat P, Nubret K, Amour J, Vermes E, Ou P, Guendouz S, Chevalier P, Lebreton G, Flecher E, Obadia JF, Logeart D, de Groote P.

Arch Cardiovasc Dis. 2018 Feb;111(2):126-139. doi: 10.1016/j.acvd.2017.12.001. Epub 2017 Dec 23. Review.

10.

Factors associated with the 6-minute walk distance in patients with systemic sclerosis.

Sanges S, Giovannelli J, Sobanski V, Morell-Dubois S, Maillard H, Lambert M, Podevin C, Lamblin N, De Groote P, Bervar JF, Perez T, Matran R, Rémy-Jardin M, Hatron PY, Hachulla É, Launay D.

Arthritis Res Ther. 2017 Dec 15;19(1):279. doi: 10.1186/s13075-017-1489-4.

11.

Long-term prognostic impact of left ventricular remodeling after a first myocardial infarction in modern clinical practice.

Bauters C, Dubois E, Porouchani S, Saloux E, Fertin M, de Groote P, Lamblin N, Pinet F.

PLoS One. 2017 Nov 27;12(11):e0188884. doi: 10.1371/journal.pone.0188884. eCollection 2017.

12.

Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension.

Boucly A, Weatherald J, Savale L, Jaïs X, Cottin V, Prevot G, Picard F, de Groote P, Jevnikar M, Bergot E, Chaouat A, Chabanne C, Bourdin A, Parent F, Montani D, Simonneau G, Humbert M, Sitbon O.

Eur Respir J. 2017 Aug 3;50(2). pii: 1700889. doi: 10.1183/13993003.00889-2017. Print 2017 Aug.

13.

2D-speckle tracking right ventricular strain to assess right ventricular systolic function in systolic heart failure. Analysis of the right ventricular free and posterolateral walls.

Mouton S, Ridon H, Fertin M, Pentiah AD, Goémine C, Petyt G, Lamblin N, Coisne A, Foucher-Hossein C, Montaigne D, de Groote P.

Int J Cardiol. 2017 Oct 15;245:190-195. doi: 10.1016/j.ijcard.2017.07.077. Epub 2017 Jul 25.

PMID:
28768580
14.

Subacute right heart failure revealing three simultaneous causes of post-embolic pulmonary hypertension in metastatic dissemination of breast cancer.

Vincent F, Lamblin N, Classe M, Schurtz G, Rauch A, Fertin M, De Groote P.

ESC Heart Fail. 2017 Feb;4(1):75-77. doi: 10.1002/ehf2.12106. Epub 2016 Dec 6.

15.

New guidelines, new recommendations! But what is really new? A pragmatic interpretation of the 2016 European guidelines for the management of chronic heart failure.

de Groote P, Cohen A, Juillière Y, Damy T.

Arch Cardiovasc Dis. 2017 Jan;110(1):1-6. doi: 10.1016/j.acvd.2016.12.001. Epub 2017 Jan 9. No abstract available.

16.

Preclinical Development of a MicroRNA-Based Therapy for Elderly Patients With Myocardial Infarction.

Gupta SK, Foinquinos A, Thum S, Remke J, Zimmer K, Bauters C, de Groote P, Boon RA, de Windt LJ, Preissl S, Hein L, Batkai S, Pinet F, Thum T.

J Am Coll Cardiol. 2016 Oct 4;68(14):1557-71. doi: 10.1016/j.jacc.2016.07.739.

17.

Effect of left ventricular systolic dysfunction on secondary medical prevention and clinical outcome in stable coronary artery disease patients.

Lamblin N, Meurice T, Tricot O, Lemesle G, Deneve M, de Groote P, Bauters C.

Arch Cardiovasc Dis. 2017 Jan;110(1):35-41. doi: 10.1016/j.acvd.2016.04.003. Epub 2016 Aug 31.

18.

[Tolerance of bevacizumab therapy in systemic sclerosis-associated pulmonary arterial hypertension: A case report].

Sanges S, Desauw C, de Groote P, Fertin M, Lamblin N, Bervar JF, Hatron PY, Hachulla E, Launay D.

Rev Med Interne. 2017 Apr;38(4):274-277. doi: 10.1016/j.revmed.2016.05.020. Epub 2016 Jun 28. French.

PMID:
27370897
19.

A systematic review and meta-regression of temporal trends in the excess mortality associated with diabetes mellitus after myocardial infarction.

Bauters C, Lemesle G, de Groote P, Lamblin N.

Int J Cardiol. 2016 Aug 15;217:109-21. doi: 10.1016/j.ijcard.2016.04.182. Epub 2016 May 4. Review.

PMID:
27179900
20.

Generation of a new Gateway-compatible inducible lentiviral vector platform allowing easy derivation of co-transduced cells.

De Groote P, Grootjans S, Lippens S, Eichperger C, Leurs K, Kahr I, Tanghe G, Bruggeman I, De Schamphelaire W, Urwyler C, Vandenabeele P, Haustraete J, Declercq W.

Biotechniques. 2016 May 1;60(5):252-9. doi: 10.2144/000114417. eCollection 2016.

21.

Vaccination with Necroptotic Cancer Cells Induces Efficient Anti-tumor Immunity.

Aaes TL, Kaczmarek A, Delvaeye T, De Craene B, De Koker S, Heyndrickx L, Delrue I, Taminau J, Wiernicki B, De Groote P, Garg AD, Leybaert L, Grooten J, Bertrand MJ, Agostinis P, Berx G, Declercq W, Vandenabeele P, Krysko DV.

Cell Rep. 2016 Apr 12;15(2):274-87. doi: 10.1016/j.celrep.2016.03.037. Epub 2016 Mar 31.

22.

Right ventricular systolic function in heart failure: A long story but still the same question.

de Groote P.

Arch Cardiovasc Dis. 2016 Apr;109(4):227-30. doi: 10.1016/j.acvd.2016.02.001. Epub 2016 Mar 28. No abstract available.

23.

Initial dual oral combination therapy in pulmonary arterial hypertension.

Sitbon O, Sattler C, Bertoletti L, Savale L, Cottin V, Jaïs X, De Groote P, Chaouat A, Chabannes C, Bergot E, Bouvaist H, Dauphin C, Bourdin A, Bauer F, Montani D, Humbert M, Simonneau G.

Eur Respir J. 2016 Jun;47(6):1727-36. doi: 10.1183/13993003.02043-2015. Epub 2016 Mar 17.

24.

Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases.

Pinto YM, Elliott PM, Arbustini E, Adler Y, Anastasakis A, Böhm M, Duboc D, Gimeno J, de Groote P, Imazio M, Heymans S, Klingel K, Komajda M, Limongelli G, Linhart A, Mogensen J, Moon J, Pieper PG, Seferovic PM, Schueler S, Zamorano JL, Caforio AL, Charron P.

Eur Heart J. 2016 Jun 14;37(23):1850-8. doi: 10.1093/eurheartj/ehv727. Epub 2016 Jan 19. Review.

PMID:
26792875
25.

A prospective study of the 6 min walk test as a surrogate marker for haemodynamics in two independent cohorts of treatment-naïve systemic sclerosis-associated pulmonary arterial hypertension.

Sanges S, Launay D, Rhee RL, Sitbon O, Hachulla É, Mouthon L, Guillevin L, Rottat L, Montani D, De Groote P, Cottin V, Magro P, Prévot G, Bauer F, Bergot E, Chabanne C, Reynaud-Gaubert M, Leroy S, Canuet M, Sanchez O, Gut-Gobert C, Dauphin C, Pison C, Boissin C, Habib G, Clerson P, Conesa F, Cordier JF, Kawut SM, Simonneau G, Humbert M.

Ann Rheum Dis. 2016 Aug;75(8):1457-65. doi: 10.1136/annrheumdis-2015-207336. Epub 2015 Aug 31.

PMID:
26324844
26.

Recurrent suspected myocarditis combined with infrahisian conduction disturbances revealing a desminopathy.

Boulé S, Richard P, de Groote P, Renaud F, Charron P.

HeartRhythm Case Rep. 2015 Jun 9;1(5):305-309. doi: 10.1016/j.hrcr.2015.04.002. eCollection 2015 Sep. No abstract available.

27.

Sildenafil in heart transplant candidates with pulmonary hypertension.

de Groote P, El Asri C, Fertin M, Goéminne C, Vincentelli A, Robin E, Duva-Pentiah A, Lamblin N.

Arch Cardiovasc Dis. 2015 Jun-Jul;108(6-7):375-84. doi: 10.1016/j.acvd.2015.01.013. Epub 2015 Apr 25.

28.

Multimarker proteomic profiling for the prediction of cardiovascular mortality in patients with chronic heart failure.

Lemesle G, Maury F, Beseme O, Ovart L, Amouyel P, Lamblin N, de Groote P, Bauters C, Pinet F.

PLoS One. 2015 Apr 23;10(4):e0119265. doi: 10.1371/journal.pone.0119265. eCollection 2015.

29.

Involvement of BAG3 and HSPB7 loci in various etiologies of systolic heart failure: Results of a European collaboration assembling more than 2000 patients.

Garnier S, Hengstenberg C, Lamblin N, Dubourg O, De Groote P, Fauchier L, Trochu JN, Arbustini E, Esslinger U, Barton PJ, Meder B, Katus H, Frese K, Komajda M, Cook SA, Isnard R, Tiret L, Villard E, Charron P.

Int J Cardiol. 2015;189:105-7. doi: 10.1016/j.ijcard.2015.04.003. Epub 2015 Apr 1. No abstract available.

30.

An original cause of pulmonary hypertension.

Domanski O, Algeri E, Fertin M, Petit G, Lamblin N, Rémy-Jardin M, de Groote P.

Int J Cardiol. 2015 Mar 1;182:4-5. doi: 10.1016/j.ijcard.2014.12.104. Epub 2014 Dec 27. No abstract available.

PMID:
25597979
31.

Percutaneous transaortic valve implantation for severe aortic regurgitation in a patient with a porto-pulmonary hypertension.

Hebbar E, Fertin M, Delhaye C, Richardson M, Modine T, Sudre A, Lamblin N, de Groote P.

Int J Cardiol. 2015 Mar 1;182:72-3. doi: 10.1016/j.ijcard.2014.12.142. Epub 2014 Dec 30. No abstract available.

PMID:
25576724
32.

A novel RIPK4-IRF6 connection is required to prevent epithelial fusions characteristic for popliteal pterygium syndromes.

De Groote P, Tran HT, Fransen M, Tanghe G, Urwyler C, De Craene B, Leurs K, Gilbert B, Van Imschoot G, De Rycke R, Guérin CJ, Holland P, Berx G, Vandenabeele P, Lippens S, Vleminckx K, Declercq W.

Cell Death Differ. 2015 Jun;22(6):1012-24. doi: 10.1038/cdd.2014.191. Epub 2014 Nov 28.

33.

Diagnosis and treatment of iron deficiency in patients with heart failure: expert position paper from French cardiologists.

Cohen-Solal A, Leclercq C, Mebazaa A, De Groote P, Damy T, Isnard R, Galinier M.

Arch Cardiovasc Dis. 2014 Oct;107(10):563-71. doi: 10.1016/j.acvd.2014.07.049. Epub 2014 Sep 17. Review.

34.

Iron deficiency: an emerging therapeutic target in heart failure.

Cohen-Solal A, Leclercq C, Deray G, Lasocki S, Zambrowski JJ, Mebazaa A, de Groote P, Damy T, Galinier M.

Heart. 2014 Sep 15;100(18):1414-20. doi: 10.1136/heartjnl-2014-305669. Epub 2014 Jun 23. Review.

PMID:
24957529
35.

Prognostic impact of ß-blocker use in patients with stable coronary artery disease.

Bauters C, Lemesle G, Meurice T, Tricot O, de Groote P, Lamblin N.

Heart. 2014 Nov;100(22):1757-61. doi: 10.1136/heartjnl-2014-305719. Epub 2014 Jun 19.

PMID:
24947319
36.

Circulating long noncoding RNA, LIPCAR, predicts survival in patients with heart failure.

Kumarswamy R, Bauters C, Volkmann I, Maury F, Fetisch J, Holzmann A, Lemesle G, de Groote P, Pinet F, Thum T.

Circ Res. 2014 May 9;114(10):1569-75. doi: 10.1161/CIRCRESAHA.114.303915. Epub 2014 Mar 24.

PMID:
24663402
37.

Long-term functional and clinical follow-up of patients with heart failure with recovered left ventricular ejection fraction after β-blocker therapy.

de Groote P, Fertin M, Duva Pentiah A, Goéminne C, Lamblin N, Bauters C.

Circ Heart Fail. 2014 May;7(3):434-9. doi: 10.1161/CIRCHEARTFAILURE.113.000813. Epub 2014 Feb 21.

PMID:
24563449
38.

Current epoprostenol use in patients with severe idiopathic, heritable or anorexigen-associated pulmonary arterial hypertension: data from the French pulmonary hypertension registry.

Bergot E, Sitbon O, Cottin V, Prévot G, Canuet M, Bourdin A, de Groote P, Rottat L, Gressin V, Jaïs X, Humbert M, Simonneau G.

Int J Cardiol. 2014 Apr 1;172(3):561-7. doi: 10.1016/j.ijcard.2013.12.313. Epub 2014 Jan 22.

PMID:
24529947
39.

Prevalence of memory disorders in ambulatory patients aged ≥70 years with chronic heart failure (from the EFICARE study).

Hanon O, Vidal JS, de Groote P, Galinier M, Isnard R, Logeart D, Komajda M.

Am J Cardiol. 2014 Apr 1;113(7):1205-10. doi: 10.1016/j.amjcard.2013.12.032. Epub 2014 Jan 15.

PMID:
24507171
40.

Clinical implications of left ventricular assist device implantation in patients with an implantable cardioverter-defibrillator.

Boudghène-Stambouli F, Boulé S, Goéminne C, Botcherby E, Marquié C, Kouakam C, Guédon-Moreau L, Schurtz G, de Groote P, Lamblin N, Fertin M, Robin E, Brigadeau F, Klug D, Lacroix D, Meurice J, Wissocque L, Vincentelli A, Kacet S.

J Interv Card Electrophysiol. 2014 Mar;39(2):177-84. doi: 10.1007/s10840-013-9854-y. Epub 2013 Dec 13.

PMID:
24338204
41.

Relevance of partitioning DLCO to detect pulmonary hypertension in systemic sclerosis.

Sivova N, Launay D, Wémeau-Stervinou L, De Groote P, Remy-Jardin M, Denis G, Lambert M, Lamblin N, Morell-Dubois S, Fertin M, Lefevre G, Sobanski V, Le Rouzic O, Hatron PY, Wallaert B, Hachulla E, Perez T.

PLoS One. 2013 Oct 18;8(10):e78001. doi: 10.1371/journal.pone.0078001. eCollection 2013.

42.

Caspase-14 overexpression in hairless mice is not involved in utricle formation.

Devos M, De Groote P, Gilbert B, Bruggeman I, Leurs K, Lippens S, Vandenabeele P, Declercq W.

Exp Dermatol. 2013 Jul;22(7):484-6. doi: 10.1111/exd.12165.

PMID:
23800061
43.

CDK4 T172 phosphorylation is central in a CDK7-dependent bidirectional CDK4/CDK2 interplay mediated by p21 phosphorylation at the restriction point.

Bisteau X, Paternot S, Colleoni B, Ecker K, Coulonval K, De Groote P, Declercq W, Hengst L, Roger PP.

PLoS Genet. 2013 May;9(5):e1003546. doi: 10.1371/journal.pgen.1003546. Epub 2013 May 30.

44.

New technologies, new therapies: toward personalized medicine in heart failure patients?

de Groote P, Pinet F, Bauters C.

Eur Heart J. 2013 Mar;34(9):636-7. doi: 10.1093/eurheartj/ehs432. Epub 2012 Dec 20. No abstract available.

PMID:
23257952
45.

Current aspects of the spectrum of acute heart failure syndromes in a real-life setting: the OFICA study.

Logeart D, Isnard R, Resche-Rigon M, Seronde MF, de Groote P, Jondeau G, Galinier M, Mulak G, Donal E, Delahaye F, Juilliere Y, Damy T, Jourdain P, Bauer F, Eicher JC, Neuder Y, Trochu JN; Heart Failure of the French Society of Cardiology.

Eur J Heart Fail. 2013 Apr;15(4):465-76. doi: 10.1093/eurjhf/hfs189. Epub 2012 Nov 27.

46.

Expanding the phenotype associated with a desmoplakin dominant mutation: Carvajal/Naxos syndrome associated with leukonychia and oligodontia.

Boulé S, Fressart V, Laux D, Mallet A, Simon F, de Groote P, Bonnet D, Klug D, Charron P.

Int J Cardiol. 2012 Nov 1;161(1):50-2. doi: 10.1016/j.ijcard.2012.06.068. Epub 2012 Jul 12. No abstract available.

PMID:
22795705
47.

Cardiac remodeling and heart failure after a first anterior myocardial infarction in patients with diabetes mellitus.

Lamblin N, Fertin M, de Groote P, Bauters C.

J Cardiovasc Med (Hagerstown). 2012 Jun;13(6):353-9. doi: 10.2459/JCM.0b013e328353694b.

PMID:
22498999
48.

Right ventricular systolic function for risk stratification in patients with stable left ventricular systolic dysfunction: comparison of radionuclide angiography to echoDoppler parameters.

de Groote P, Fertin M, Goéminne C, Petyt G, Peyrot S, Foucher-Hossein C, Mouquet F, Bauters C, Lamblin N.

Eur Heart J. 2012 Nov;33(21):2672-9. doi: 10.1093/eurheartj/ehs080. Epub 2012 Mar 27.

PMID:
22453651
49.

Unexpected and rapid recovery of left ventricular function in patients with peripartum cardiomyopathy: impact of cardiac resynchronization therapy.

Mouquet F, Mostefa Kara M, Lamblin N, Coulon C, Langlois S, Marquie C, de Groote P.

Eur J Heart Fail. 2012 May;14(5):526-9. doi: 10.1093/eurjhf/hfs031. Epub 2012 Mar 23.

50.

Incidence, determinants and consequences of left atrial remodelling after a first anterior myocardial infarction.

Lamblin N, Fertin M, de Groote P, Bauters C.

Arch Cardiovasc Dis. 2012 Jan;105(1):18-23. doi: 10.1016/j.acvd.2011.11.001. Epub 2012 Jan 14.

Supplemental Content

Loading ...
Support Center